---
title: "STOCKS | Hutchmed (China) Says ORPATHYS Approved in China for MET-Amplified GC/GEJ Cancer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291533973.md"
description: "Hutchmed (China) (0013) said China’s National Medical Products Administration has granted conditional approval for a new drug application for ORPATHYS (savolitinib), according to Ming Pao. The company said the approval is for treating adult patients with locally advanced or metastatic gastric cancer or gastroesophageal junction (GC/GEJ) adenocarcinoma with MET gene amplification who have failed at least two systemic therapies."
datetime: "2026-07-02T10:33:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291533973.md)
  - [en](https://longbridge.com/en/news/291533973.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291533973.md)
---

# STOCKS | Hutchmed (China) Says ORPATHYS Approved in China for MET-Amplified GC/GEJ Cancer

Hutchmed (China) (0013) said China’s National Medical Products Administration has granted conditional approval for a new drug application for ORPATHYS (savolitinib), according to Ming Pao. The company said the approval is for treating adult patients with locally advanced or metastatic gastric cancer or gastroesophageal junction (GC/GEJ) adenocarcinoma with MET gene amplification who have failed at least two systemic therapies.

### Related Stocks

- [00013.HK](https://longbridge.com/en/quote/00013.HK.md)
- [HCM.US](https://longbridge.com/en/quote/HCM.US.md)

## Related News & Research

- [HUTCHMED's Experimental Drug Shows Durable Responses In Advanced Bile Duct Cancer Trial](https://longbridge.com/en/news/290858754.md)
- [Lauxera Capital Partners invests in GenePlanet in private funding round](https://longbridge.com/en/news/294314706.md)
- [Adult epilepsy market to reach $17.bn across 7MM by 2035](https://longbridge.com/en/news/293805836.md)
- [Dynam Japan Clarifies Sato Family Shareholding Shift Amid Intra-Family Transfer](https://longbridge.com/en/news/294329531.md)
- [Generational Group Advises Lampert's Home Therapy, Inc. in its Sale to a Private Investor](https://longbridge.com/en/news/294091391.md)